首页> 外文期刊>FEBS letters. >Glucocorticoid induces mesenchymal-to-epithelial transition and inhibits TGF-beta1-induced epithelial-to-mesenchymal transition and cell migration.
【24h】

Glucocorticoid induces mesenchymal-to-epithelial transition and inhibits TGF-beta1-induced epithelial-to-mesenchymal transition and cell migration.

机译:糖皮质激素诱导间质到上皮的转变,并抑制TGF-β1诱导的上皮到间充质的转变和细胞迁移。

获取原文
获取原文并翻译 | 示例
           

摘要

Epithelial-to-mesenchymal transition (EMT) has been implicated in various physiological and pathological events. In this study, we found that the synthetic glucocorticoid dexamethasone (Dex) can inhibit transforming growth factor-beta1-induced EMT and cell migration. We also demonstrated that Dex inhibits EMT through a mechanism involving the suppression of ROS generation. Surprisingly, Dex alone induced mesenchymal-to-epithelial transition (MET). Dexamethasone treatment abolished Snail1 binding to the E-cadherin promoter, suggesting that suppression of Snail1 contributes to the above roles of Dex. Our findings demonstrate that Dex functions as both a suppressor of EMT and as an inducer of MET and therefore may be implicated in certain pathophysiological events.
机译:上皮到间充质转变(EMT)已牵涉到各种生理和病理事件。在这项研究中,我们发现合成的糖皮质激素地塞米松(Dex)可以抑制转化生长因子-β1诱导的EMT和细胞迁移。我们还证明了Dex通过涉及抑制ROS生成的机制抑制EMT。出人意料的是,单独的Dex诱导了间质到上皮的转变(MET)。地塞米松治疗取消了Snail1与E-cadherin启动子的结合,这表明Snail1的抑制有助于Dex的上述作用。我们的发现表明,Dex既可作为EMT的抑制剂,又可作为MET的诱导剂,因此可能与某些病理生理事件有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号